File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Effect of oral erythromycin on gastric and small bowel transit time of capsule endoscopy

TitleEffect of oral erythromycin on gastric and small bowel transit time of capsule endoscopy
Authors
KeywordsCapsule endoscopy
Erythromycin
Prokinetic
Issue Date2005
PublisherBaishideng Publishing Group. The Journal's web site is located at http://www.wjgnet.com/1007-9327/index.htm
Citation
World Journal Of Gastroenterology, 2005, v. 11 n. 31, p. 4865-4868 How to Cite?
AbstractAim: To determine the effect of oral erythromycin on gastric and small bowel transit time of capsule endoscopy. Methods: Consecutive patients who underwent capsule endoscopy during the 16-mo study period were either given 250 mg oral erythromycin, 1 h prior to swallowing the capsule endoscope or nothing. The gastric and small bowel transit time, and the small bowel image quality were compared. Results: Twenty-four patients received oral erythromycin whereas 14 patients were not given any prokinetic agent. Patients who received erythromycin had a significantly lower gastric transit time than control (16 min vs 70 min, P = 0.005), whereas the small bowel transit time was comparable between the two groups (227 min vs 183 min, P = 0.18). Incomplete small bowel examination was found in three patients of the control group and in one patient of the erythromycin group. There was no significant difference in the overall quality of small bowel images between the two groups. A marked reduction in gastric transit time was noted in two patients who had repeat capsule endoscopy after oral erythromycin. Conclusion: Use of oral erythromycin significantly reduces the gastric transit time of capsule endoscopy. © 2005 The WJG Press and Elsevier Inc. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/162874
ISSN
2023 Impact Factor: 4.3
2023 SCImago Journal Rankings: 1.063
PubMed Central ID
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorLeung, WLen_US
dc.contributor.authorChan, FKLen_US
dc.contributor.authorFung, SSLen_US
dc.contributor.authorWong, MYen_US
dc.contributor.authorSung, JJYen_US
dc.date.accessioned2012-09-05T05:24:38Z-
dc.date.available2012-09-05T05:24:38Z-
dc.date.issued2005en_US
dc.identifier.citationWorld Journal Of Gastroenterology, 2005, v. 11 n. 31, p. 4865-4868en_US
dc.identifier.issn1007-9327en_US
dc.identifier.urihttp://hdl.handle.net/10722/162874-
dc.description.abstractAim: To determine the effect of oral erythromycin on gastric and small bowel transit time of capsule endoscopy. Methods: Consecutive patients who underwent capsule endoscopy during the 16-mo study period were either given 250 mg oral erythromycin, 1 h prior to swallowing the capsule endoscope or nothing. The gastric and small bowel transit time, and the small bowel image quality were compared. Results: Twenty-four patients received oral erythromycin whereas 14 patients were not given any prokinetic agent. Patients who received erythromycin had a significantly lower gastric transit time than control (16 min vs 70 min, P = 0.005), whereas the small bowel transit time was comparable between the two groups (227 min vs 183 min, P = 0.18). Incomplete small bowel examination was found in three patients of the control group and in one patient of the erythromycin group. There was no significant difference in the overall quality of small bowel images between the two groups. A marked reduction in gastric transit time was noted in two patients who had repeat capsule endoscopy after oral erythromycin. Conclusion: Use of oral erythromycin significantly reduces the gastric transit time of capsule endoscopy. © 2005 The WJG Press and Elsevier Inc. All rights reserved.en_US
dc.languageengen_US
dc.publisherBaishideng Publishing Group. The Journal's web site is located at http://www.wjgnet.com/1007-9327/index.htmen_US
dc.relation.ispartofWorld Journal of Gastroenterologyen_US
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCapsule endoscopy-
dc.subjectErythromycin-
dc.subjectProkinetic-
dc.subject.meshBody Mass Indexen_US
dc.subject.meshCapsulesen_US
dc.subject.meshEndoscopy, Gastrointestinal - Methodsen_US
dc.subject.meshErythromycin - Pharmacologyen_US
dc.subject.meshFemaleen_US
dc.subject.meshGastrointestinal Transit - Drug Effects - Physiologyen_US
dc.subject.meshHumansen_US
dc.subject.meshIntestine, Small - Drug Effects - Physiologyen_US
dc.subject.meshKineticsen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshStomach - Drug Effects - Physiologyen_US
dc.titleEffect of oral erythromycin on gastric and small bowel transit time of capsule endoscopyen_US
dc.typeArticleen_US
dc.identifier.emailLeung, WL:waikleung@hku.hken_US
dc.identifier.authorityLeung, WL=rp01479en_US
dc.description.naturepublished_or_final_versionen_US
dc.identifier.doi10.3748/wjg.v11.i31.4865-
dc.identifier.pmid16097060-
dc.identifier.pmcidPMC4398738-
dc.identifier.scopuseid_2-s2.0-24044448495en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-24044448495&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume11en_US
dc.identifier.issue31en_US
dc.identifier.spage4865en_US
dc.identifier.epage4868en_US
dc.identifier.isiWOS:000208317800018-
dc.publisher.placeChinaen_US
dc.identifier.scopusauthoridLeung, WL=7201504523en_US
dc.identifier.scopusauthoridChan, FKL=7202586434en_US
dc.identifier.scopusauthoridFung, SSL=7201970030en_US
dc.identifier.scopusauthoridWong, MY=8549225600en_US
dc.identifier.scopusauthoridSung, JJY=35405352400en_US
dc.identifier.issnl1007-9327-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats